Adopts multi-stage crystallization and spray drying technology to ensure extremely high purity and low moisture content, avoiding impurity contamination in preparations. The sterile packaging design adapts to the cleanliness requirements of injection production, reducing the purification treatment cost of downstream pharmaceutical enterprises. The precisely controlled particle size ensures rapid dissolution in the preparation system, improving production efficiency. It strictly follows pharmacopoeia standards and passes third-party testing certification, can be directly used in the production of injectable and oral pharmaceutical products, helping pharmaceutical enterprises pass drug regulatory audits quickly.
Detailed parameters include: purity ≥99.9%, moisture content ≤0.5%, pH value of 10% aqueous solution 5.5-7.5, heavy metals (calculated as Pb) ≤5 ppm, arsenic ≤1 ppm, ignition residue ≤0.1%, particle size 30-60 mesh, packaged in 10kg sterile kraft paper composite drums, complying with GMP production packaging requirements, shelf life of 36 months. Storage conditions: cool, dry and clean place, avoid storing with corrosive articles.
Mainly used in injectable magnesium salt preparations (such as magnesium sulfate injection), oral laxative preparations, active ingredients of external anti-inflammatory lotions, and also used as chelating agent and osmotic pressure regulator in pharmaceutical processes. It adapts to domestic pharmaceutical factories, generic drug R&D enterprises, pharmaceutical raw material traders, helping customers meet the strict compliance requirements of pharmaceutical production and adapting to the procurement demands of the global pharmaceutical supply chain.
Post RFQ
Chat
ALL CATEGORIES